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ABSTRACT
Quantification of bacterial shedding from the respiratory tract of
health care workers wearing PAPRs and other types of AirPurifying Respirators on sterile conditions in a simulated Operating
Rooms (ORs)
Segun Olanrewaju Ajewole
The role of powered air-purifying respirators (PAPRs) in healthcare settings during infectious
diseases outbreaks or use with highly contagious pathogens (e.g., SARS, HINI, and Ebola, etc.)
has attracted much interest based on their many beneficial features. A common practice to
minimize airborne contaminant exposure among healthcare workers has been using surgical masks
(SMs) or N95 filtering facepiece respirators (FFRs). However, SMs have been shown to offer
minimal respiratory protection. N95 filtering facepiece respirators (FFRs) have been shown to
provide better protection than SMs; however, they have been found uncomfortable to use for
prolonged periods. In current PAPR designs, exhaled air from the wearer is not filtered before
release to the environment. This design suggests a potential for biocontamination if used in an
operating room sterile field condition. The objective of this research is to evaluate the effect of
bacterial shedding from the respiratory tract of healthcare workers wearing PAPRs and half-mask
respirators on sterile conditions in operating rooms (ORs).
Firstly, a pilot study was conducted in a laboratory setting to determine the appropriate
sampling methodology to use in the sterile field setting. Both passive sampling (settle plate
method) and active sampling (Andersen cascade impactor sampler and SKC Bio sampler
impinger) were evaluated. Settling plates were used for a sampling period of 45 minutes, and both

active sampling methods were used for 15 minutes. During sampling, two subjects, each donning
an elastomeric half-mask, performed activities such as reading the rainbow passages and rotating
around a simulated patient manikin while sampling was being done. The results suggest that active
sampling with the use of Andersen N6 single-stage cascade impactor collected more colonyforming units when compared to the settling plates of the SKC Bio sampler.
After the pilot study, a randomized, simulated workplace study was conducted to compare the
bacterial shedding from respiratory tracts of 9 teams of 2 participants, each wearing six different
types of respiratory protection devices (RPD), including an FDA approved surgical mask (SM),
and five different NIOSH certified respirators. The NIOSH certified devices were two N95
filtering facepiece respirators (FFR), one with and one without an exhalation valve, an
elastomeric half facepiece respirator (EHMR) equipped with an exhalation valve, and two
PAPRs, one having an assigned protection factor (APF) of 25 and one with an APF of 1000.
Sterile field contamination resulting from the use of the FDA-approved surgical mask was used
as a baseline for comparison with the NIOSH-certified devices. Contamination was determined
by active biological sampling using ' 'sheep's blood agar plates. Collected samples were
incubated, and the resulting bacterial colony-forming units (CFU) were counted. The primary
outcome was expressed as concentration, the number of CFU/m3. Poisson regression analyses
were used to evaluate the concentration of CFU/m3 resulting from the use of the surgical mask as
compared to the other RPDs. A Bonferroni pairwise comparison was used to estimate the
difference between the respirators. The study was conducted between February and March 2021
at the WV Simulation Training & Education for Patient Safety laboratory at Ruby Memorial
Hospital, Morgantown, WV. Two identical simulated OR rooms were used. Each had a volume
dimension of 13.'5' x 13.'5' x '8' with an air exchange rate (AER) of 25 per hour. 18 participants

grouped into nine teams of two completed the study. The data analysis found that the bacterial
contamination produced by a pair of subjects wearing the N95 FFR without exhalation valves,
the PAPR with APF=25, and the PAPR with APF=1000 was not significantly different than the
contamination resulting from wearing the SM. The bacterial contamination resulting from using
the N95 FFR with exhalation valve and EHMR with exhalation valve was found to be
significantly higher than the bacterial contamination resulting from wearing the SM.
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Chapter 1: Introduction
1.1.

Background
In healthcare settings, a common practice to minimize airborne contaminant exposure

among healthcare workers is to use surgical masks or N95 filtering facepiece respirators (FFRs).
Various studies have shown surgical masks offer minimal respiratory protection, and while N95
filtering facepiece respirators offer better respiratory protection, they are not as comfortable to
use (Davidson et al., 2013). Surgical masks are classified as a medical device, not a respirator.
Therefore, surgical masks need to be approved by the Food and Drug Administration (FDA) (FDA,
2018).
N95 FFRs are negative pressure devices. All such devices are associated with elevated
breathing resistance. Their disadvantages include requiring an initial and periodic fit testing, the
possibility of being compromised by an improper fit (e.g., because of facial hair), poor tolerance
by users due to breathing resistance, and heat and moisture build-up, the high cost of stocking
different types and sizes, and the potential for contamination due to exposed face and neck
(Roberts, 2014).
The effect of exhaled moisture upon the breathing resistance of FFR has been mentioned
anecdotally (Mardimae et al., 2006) (Bailar et al., 2006); (Weiss et al., 2007); (Roberge et al.,
2010); (Khaw et al., 2008), but scientific data are lacking to either establish or refute this claim.
The presumption is that exhaled moisture clogs the voids in the fibrous filtration media (primarily
by condensation), thereby increasing the breathing resistance (Mardimae et al., 2006; Roberge et
al., 2010). A survey entitled """Prevalence of Respiratory Protective Devices in USS Healthcare
Facilities""", conducted in 2014 found that NIOSH-certified N95 FFRs were the most widely used
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respiratory protection device (RPD) in healthcare environments, followed by powered airpurifying respirators (PAPRs). (Wizner et al., 2016)
N95 FFRs continue to be the most prevalent RPD used by health care workers (HCWs);
however, increasing use of PAPRs in health care indicates the need for targeted education based
on regional trends tailored to the types of RPDs used in health care facilities. (Wizner et al., 2016)
Recently, much interest has been directed towards the role of PAPRs in healthcare settings
during infectious disease outbreaks, based upon multiple advantageous features like greater '
'wearer's comfort, no fit testing requirements, and improved physiological parameters (Wizner et
al., 2016). The use of HEPA filters in PAPRs implies that they have a greater level of respiratory
protection than in N95 masks due to the ability of the HEPA filters to filter at least 99.97% of
particles 0.3µm in diameter and their oil proof nature. (Roberts, 2014)
More than 11 million HCWs are expected to benefit from the use of RPDs during an
infectious respiratory pandemic (Cooley et al., 2010). Since the outbreaks of SARS in 2003, H1N1
in 2009, and Ebola in 2015, more attention has been focused on using PAPRs for HCWs (Board
on Health Sciences Policy & Institute of Medicine, 2015).
1.1.1 Pilot Study Background
Initial work in this area was conducted by the University of Cincinnati and Tyler Church
at West Virginia University. These studies did find some evidence of bacterial shedding by
persons wearing PAPRs and surgical masks. The methodological approach taken in the
Cincinnati study was to have HCWs perform simulated work activities over the period of an hour
in a simulated OR setting. Bacterial shedding was assessed by collecting viable colony forming
units (CFU) using a settling plate method. While bacterial collection by settling plate is a
recognized sampling method, it relies on the bacterial particles settling out of the air onto an agar
plate. One of the identified problems with this method is the settling rate of small particle sizes.
2

In the Cincinnati study, assuming the distance from the ' 'subject's head to the top of the hospital
bed was 3 ft, the settling plate sampling method would grossly under-sample particle sizes of
3um or less. Even particle sizes between 3um and 10um would be under-sampled. The same
analysis holds true for the Church study at WVU. Particle mechanics calculations of settling
times for unit density spheres indicated that the time to settle 5ft ranges from ≈41 hrs. for a
0.5µm particle to ≈8 minutes for a 10µm particle.
A second shortcoming of both the Cincinnati and Church studies is failure to consider the time
required for the bacterial concentration in the test room to reach equilibrium or that homogenous
mixing has occurred. Given this shortcoming in the methodology, it is not surprising that the
CFUs were almost solely found on settling plates located very close to where the test subjects
were doing their simulated work activities. This observation was recorded in both the Cincinnati
and Church studies.
Before beginning the main OR study, a pilot study was conducted to evaluate the collection
efficiency of different passive and active bacterial sampling methods, bacterial concentration
equilibrium, and homogeneity in the test room. This pilot study evaluated different active
sampling methods to replace settling plate sampling and more thoroughly consider issues of
bacterial concentration equilibrium and homogeneity in the test room. The pilot study was
conducted with an elastomeric half-mask respirator (EHMR) and two test participants.
1.1.2 Pilot Study Samplers and Sampling Procedure
We evaluated four sampling methods: the settling plate method, the Andersen 6-stage biological
sampler, the Anderson single stage biological sampler and the SKC """Bio-sampler" liquid
impinger.
1.1.2.1 Andersen 6 Stage and Single Stage Bioaerosol Sampler
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The Andersen bioaerosol sampler uses a 6- stage impactor to collect six aerosol fractions on the
surfaces of agar medium contained in Petri dishes. The Andersen single-stage bioaerosol
sampler uses a single stage to collect aerosol fraction on the surface of the agar medium. Petri
dishes are placed in the instrument, and the sample of air is drawn in which the corresponding
particulates are collected on the agar medium of each stage. The Petri dishes are then removed to
be incubated and counted. The general sampling procedure was as follows:
•

The sampling pump was calibrated to 28.3 L/min.

•

The impactor was cleaned inside and outside with antibacterial wipes between each test
cycle.

•

Agar plates were identified with a date, sample number, and location.

•

The agar plate cover was removed, and the plate, agar side up, was be placed on each
impactor stage.

•

Samples were to be collected initially for 1-5 minutes. This time could be adjusted
depending on the number of CFU found on the agar plates.

•

The agar plate was to be removed from the impactor stage, and the plate cover replaced
and placed in a Ziplock bag.

•

Plates were incubated at 37° C for 48 hrs. after which the CFUs were counted for each
plate

1.1.2.2 SKC """Bio-sampler" liquid impinger

The SKC """Bio-sampler" liquid impinger (Eight Four, PA, USA) is an all-glass, swirling
aerosol collector consisting of an air inlet, three tangentially arranged nozzles, and a collection
vessel.
•

The sampling pump flow rate was calibrated to 12.5 L/min.
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•

Before each use the """Bio-sampler""", including the inlet, nozzle section, collection
vessel, and ground joint cap were sterilized, in an autoclave within a range of 160° to
180° C for 180 to 240 minutes. The collection vessel were coated with petroleum
jelly/hexane solution, and ViaTrap mineral oil or glycerol was used as collection liquid.

1.1.2.3 Settling Plate Method

•

The settling plate sampling method involved the use of Remel 5% Blood Agar (TSA with
Sheep Blood) for sampling the air in the room for bacterial contamination while the
subjects donned the EHMR. The blood agar plates were placed at specific locations on
the body of a patient-simulating manikin positioned on a Surgical Table. The plates were
uncovered at the beginning of the test, covered, and removed at the end. For instance, in
the trials involving subjects, the plates were uncovered precisely when the subjects
entered the chamber, then covered and removed when the subjects finished the test and
exited. The sampled plates were then incubated at 37° C for 48 hrs. after which the CFUs
were counted for each plate.

1.1.3 Sampling Location
For the pilot testing, contamination was measured at three sampling locations of increasing
distance (1, 3, and 5 feet) from the head of the hospital bed. All three samplers (Andersen
sampler, the settling plate method and "Bio-sampler" sampler) were placed at each location.
Subjects were located at the opposite sides of the bed for each test sequence. Holding subject
location relatively constant and varying the position of samplers away from the head of the bed
allowed us to see if CFUs are sampled at more distant locations from the head of the bed.
5

1.1.4 Sampling Plates
A Thermo Scientific Blood Agar (TSA with sheep Blood) medium was used for sample
collection to facilitate bacterial growth. Agar plates were then incubated at 37 °C for 48 hours
before colony-forming units (CFU) were counted.
1.1.5 Testing Procedures for pilot testing
Two test subjects wearing an EHMR were used for the pilot study. Each test included two
subjects talking and performing specific work tasks around the hospital bed. Five-minute cycles
of talking, flipping their position on the side of the bed, and resting were repeated seven times,
making the overall test duration 45 minutes. Settling plate passive sampling occurred throughout
the period. The agar plate lid was removed at the start of the test cycle and replaced at the end of
the test cycle. The Andersen and "Bio sampler" was collected during the last five minutes of the
test cycle to prevent oversampling.
1.1.6 Sample size for the Pilot study
An elastomeric half mask was evaluated by two test subjects. Contamination was measured at
three locations of increasing distance from each test subject test, and three sampling devices
were used at each location. Six agar plates were used for the Andersen six stages sampler, and
one plate for the single-stage sampler, one for the settling plate method, and four for the SKC
liquid impinger "Bio-sampler".
The overall results suggested that the active sampling involving the use of Andersen N6 singlestage cascade impactor generates the most CFU when compared to the settling plate or “Bio
sampler sampling approaches.

1.2.

Problem Statement

Air exhaled by a person is generally expected to contain some aerosolized microorganisms.
6

When using a surgical mask or N95 FFR, which are semi-tight fitting or tight-fitting devices, the
'wearers' exhaled air leaves the mask by one or all of the following means: through the exhalation
valve; through the face seal; and back through the filter. If no exhalation valve is present, the
exhaled air passes through either the 'devices' filter or face seal. That portion passing through the
filter is filtered, thereby reducing the amount of aerosolized microorganisms released to the
ambient air. With current PAPR designs, exhaled air from the wearer is not filtered at all before
releasing to the environment. The exhalation volume is, however, diluted by the air volume
generated by the PAPR. This suggests the use of PAPRs may have the potential for greater biocontamination of sterile fields, such as an OR, compared to using surgical masks or N95 FFRs not
equipped with an exhalation valve. There is no information on potential bacterial contamination
of sterile fields from the air exhaled by healthcare workers wearing PAPR. This study will provide
data to improve recommendations/standards for PAPRs, including the use of PAPRs in sterile field
environments.

1.3.

Research Objective

This study was conducted to evaluate the effect of bacterial shedding from the respiratory
tract of healthcare workers wearing PAPRs and half-mask respirators on sterile conditions in
operating rooms (ORs).
Generalized Linear Model with categorical variables and it’s assumption

1.4.

Hypotheses

1.4.1 Specific Aims
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•

Determine the baseline contamination from the air exhaled from wearers of surgical masks

•

Measure the contamination levels from the air exhaled from wearers of PAPRs and halfmask respirators

•

Determine the difference in contamination between FFRs with and without a valve

•

Determine the difference in contamination between loose-fitting PAPRs (APF=25) and
PAPRs with hood and shroud (APF=1000)

1.4.2 Specific Hypotheses
Hypothesis 1: The air exhaled from wearers of N95 FFRs with and without an exhalation
valve, elastomeric half masks EHMR, and PAPRs generates the same overall bacterial
contamination of the sterile field in an OR as the baseline contamination when wearing a surgical
mask.
Hypothesis 2: The air exhaled from wearers of FFRs with an exhalation valve generates
the same contamination as that when wearing FFRs without an exhalation valve.

Hypothesis 3: The air exhaled from wearers of a loose-fitting PAPR (APF=25) will not increase
the level of bio-contamination compared to that when wearing PAPRs with hood and shroud
(APF=1000).

8

Chapter 2: Literature Review
Maintaining a sterile surgical field in an operating room (OR) helps prevent the surgical
environment from becoming contaminated and thus can help reduce the incidence of surgical site
infections. Historically, OR staff has used loose-fitting surgical masks cleared by FDA and
respiratory protective devices (RPDs) like NIOSH-approved surgical N95 respirators to prevent
microorganisms from the ' 'wearer's talking, exhaled breath, coughs, and sneezes from possibly
contaminating the surgical field. However, during public health emergencies, supplies of surgical
N95 respirators can become limited, and reusable options such as elastomeric half-mask respirators
and loose-fitting powered air-purifying respirators (PAPRs) should be considered.

2.1. Surgical Masks and N95 FFRs in Healthcare
Surgical masks and N95 FFRs are widely used to reduce exposure to airborne hazards in
healthcare settings, even though various research has demonstrated that surgical masks offer
minimal protection to the wearer, and N95 FFRs are not comfortable to use due to the high air
resistance of the filter (Davidson et al., 2013; Rengasamy et al., 2014). However, some N95
respirators are intended for use in a healthcare setting. Specifically, single-use, disposable
respiratory protective devices are used and worn by healthcare personnel during procedures to
protect both the patient and healthcare personnel from the transfer of microorganisms, body fluids,
and particulate material. These N95 respirators are class II devices regulated by the FDA, under
21 CFR 878.4040, and CDC NIOSH (Health, 2020). Surgical masks are not classified as a
respirator but as a medical device, thus needing to be approved by the Food and Drug
Administration (FDA) (FDA, 2018). These masks cover the nose and mouth of the user and act as
a barrier to guard against droplets contacting the patient.
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An N95 FFR can be worn in place of a surgical mask; however, it must be FDA-cleared and
NIOSH approved (FDA, 2018). Unlike the surgical mask, which can be worn by anyone, the N95
is required to be fit tested annually to provide proper protection, which can be costly and timeconsuming for a health care facility (Board on Health Sciences Policy & Institute of Medicine,
2015). In addition to time and cost, health care workers who are properly fit-tested and trained on
using an N95, may still be reluctant to wear them. Common complaints about wearing an N95
include moisture build-up, being harder to breathe after prolonged use, especially for people with
an underlying respiratory condition. Other disadvantages associated with N95 FFR include the
high cost of stocking different types and sizes, and the potential for contamination due to exposed
face and neck (Roberts, 2014).

2.2. PAPRs Applications
PAPRs were originally developed in the '1960's to protect various industrial workers from
respiratory and dermal hazards (IOM, 2015). PAPRs are increasingly used in healthcare settings
during infectious disease outbreaks. Currently, there are 18 million US healthcare workers
(HCWs) who rely on personal protective equipment (e.g., respirators, gloves, gowns, face shields,
etc.) when exposed to a range of known and unknown occupational infectious agents (CDC Health Care Workers - NIOSH Workplace Safety and Health Topic, 2020).
PAPRs use a battery-powered blower to force ambient room air through a filter, cartridge, or
canister before supplying air to the wearer. The filter removes particles, vapors, gases, or a
combination of these contaminants before they reach the ' 'wearer's breathing zone. Positive airway
pressure respirators are available in tight-fitting half- or full-face pieces or a loose-fitting facepiece
with a helmet or hood.
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PAPRs provide a higher level of protection (assigned protection factor of APF = 25 or 1000) than
the N95 FFR (APF = 10) because they supply maximally filtered air, eliminate face seal leakage,
reduce breathing difficulty encountered in negative pressure air-purifying respirators, and provide
contact protection for the head. They are also comfortable to use (especially for loose-fitting
PAPRs) because the blower produces a cooling effect by forcing air into the mask. Loose-fitting
PAPRs, unlike an N95 do not need to be fit tested to provide adequate protection, hence one of
their advantages. In addition, the constant airflow provides a cooling effect on the user, the clear
face shield will allow patients to see the worker's face, and they are reusable (Liverman et al.,
2015). Despite the added benefits, PAPRs are less common mainly due to their average cost of
$768.20 vs. $1.50 for an N95 FFR (Liverman et al., 2015). Added complaints include interferent
with communication and mobility, required maintenance (i.e., charging batteries and cleaning),
and inability to use a stethoscope. CDC primarily recommends the use of PAPRs for hospital first
responders and in the event of a large-scale disaster or for an unknown biological/ chemical threat
(CDC, 2014). Regarding an OR, CDC does not currently recommend the use of loose-fitting
PAPRs, due to fear of contamination of the sterile field (CDC, 2014).
PAPRs are designed to protect the wearer but may not adequately filter the ' 'wearer's exhaled air.
Currently, it is unknown if exhaled air may contribute to air contamination in the OR. To prevent
exhaled air from contaminating the OR, some HCWs have chosen to wear a surgical mask under
the PAPR; however, this is not a recommended practice by CDC. Current guidance from the
National Personal Protective Technology Laboratory (NPPTL) and the Association of
periOperative Registered Nurses (AORN) does not recommend the use of a PAPR in an OR due
to a lack of scientific evidence to support safe usage and the possible contamination of the '
'wearer's exhaled, unfiltered air onto the sterile field. (AORN Journal, 2015)
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Currently, no data exist on how well reusable PAPRs maintain a sterile surgical field. This lack of
data is a major concern for hospitals and will limit the adoption of reusable respirators in clinical
practice. As PAPRs have not been approved for use in OR settings, perioperative team members
often have to exercise caution when considering the use of PAPRs in the OR, weighing the risks
of a surgical site infection from contamination of the sterile field or surgical wound versus the
benefits to the health care ' 'worker's respiratory protection. The use of PAPRs in the surgical
setting is an unresolved issue that requires further research.
There were two pilot experimental studies to compare the particle concentration in an OR with and
without PAPRs being used due to the expense, time, and specialized facilities required. (Kim &
Hale, 2017) conducted a pilot study to examine the use of a PAPR in the OR and found no
discernable differences in the particulate counts at the surgical table when the PAPR-hood system
was turned on or off (ranges: 1,700-1,850 particles/cm3). They concluded that the hooded PAPR
did not increase particulate transfer to the surgical field. Grinshpun (2016) conducted another pilot
study to simulate PAPR wearers in a simulated OR to assess the bacterial contamination of sterile
field surfaces. He found that when comparing the respiratory and control groups per each agar
plate location separately, there was no statistically significant difference in the mean contamination
values associated with a specific agar plate location for either of the PAPR or N95 respirators
tested. On average, the bacterial contamination of sterile fields by a pair of subjects operating in
an OR-simulating facility while wearing either PAPRs or N95 respirators is significantly higher
than that obtained in both negative control tests.
A recent study used computational fluid dynamics (CFD) modeling to simulate and visualize the
distribution of particles exhaled by the PAPR wearer (Xu et al., 2019). In CFD simulations, the
outward release of the exhaled particles, i.e., the ratio of exhaled particle concentration outside the
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PAPR to that of inside the PAPR, was determined. The ratio of the exhaled particle concentration
outside to inside the PAPR was found to be influenced by exhaled particle sizes, breathing
workloads, and supplied-air flow rates. Outward concentration leakage from PAPR wearers was
approximately 9% with a particle size of 0.1 and 1 µm at a light work rate and 205 L/min suppliedair flow rates. Supplied air flow rates and work rates were found to have a significant impact on
outward leakage, i.e., the outward concentration leakage increased as particle size decreased,
breathing workload increased, and supplied-air flow rate decreased.
The National Institute for Occupational Safety and Health (NIOSH) tests and certifies respirators,
including PAPRs (42 CFR Part 84 Respiratory Protective Devices | NPPTL | NIOSH | CDC,
2020). There are two types of PAPR: 1) tight-fitting (full facepiece or half-mask facepiece) that is
designed to seal to the face or neck, and 2) Loose-fitting (hood, helmet, or loose-fitting facepiece)
that is designed to contact but not seal completely to the face or neck. The traditional NIOSH
certification for PAPR filters is a silica dust loading test, which simulates a work condition found
in industrial settings, primarily in mining. However, the workplace environments experienced by
HCWs differ significantly from the industrial conditions, especially when it pertains to physical
exertion when performing routine work activities. NIOSH is currently updating its certification
standard to allow a new class of PAPRs for healthcare workers. More PAPRs may become
available for healthcare workers, and the potential contamination question needs to be answered
as soon as possible.

2.3.

Microbial Air Contamination in the ORs

Basic science principles related to microbial air contamination are that microbes are dispersed
into the air by personnel in the operating room and usually are carried on skin particles (Davies
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& Noble, 1962). Contamination of surgical fields is a widely recognized cause of post-operative
infections, and the dispersion of pathogens through the air is known as a cause of healthcareassociated infections ((Da Zhou et al., 2015), (Vincent & Edwards, 2016).
Current estimates indicate that infection occurs in 0.5% to 11% of surgeries, affecting the lives
of thousands of patients each year (A report from the NNIS System, 2004).
It has been demonstrated that a correlation exists between airborne bacterial contamination and
postoperative joint sepsis in joint arthroplasty surgery (Gosden et al., 1998). Microbial
contamination of operating theaters is one of the most life-threatening sources of nosocomial
infection for patients, most especially during transplant surgery, heart surgery, etc.(Madsen et al.,
1985). There are multiple reservoirs reported to be responsible for contamination in the
healthcare environment; they include unfiltered air, ventilation systems, antiseptic solutions,
drainage of the wounds, transportation of patients and collection bags, surgical team, extent of
indoor traffic, theatre gown, foot wares, gloves and hands, use of inadequately sterilized
equipment, contaminated environment, and grossly contaminated surfaces (Fleischer et al.,
2006). A study by Edmiston et al. evaluated microbial contamination in an operating room by
means of air sampling. The study found coagulase-negative staphylococci in 51% of air samples
and staphylococcus aureus in 36% of air samples within a half meter of the wound (Edmiston et
al., 2005). Another study by Zhiqing et al. sought to determine how much contamination was
present on a surgical mask after being worn. The study compares a surgical mask worn during
procedures of varying lengths to that of a mask just sitting in an empty operating room. The
bacteria levels were significantly higher for the worn mask compared to the unused mask, while
the bacteria levels increased with time, starting at the two-hour time frame (Zhiqing et al., 2018).
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The study recommends the changing of surgical masks at this point to help reduce the chance of
infection.
While there are studies that indicate PAPRs effectiveness in protecting the user from airborne
particulates and splashes, they do not address the extent that PAPRs may inhibit user-generated
contamination from the air exhaled from affecting a sterile field or Operating Room (OR)
surfaces.

15

Chapter 3: Methods
3.1.

Study Summary

This study was conducted at the West Virginia Simulation Training & Education for Patient Safety
(STEPS) center, at the West Virginia University (WVU), Ruby Memorial Hospital, Morgantown,
WV. The STEPS center can be configured to simulate a typical OR room, as shown in figure 1.
Two identical rooms were used. Each room had a volume dimension of 13.'5' x 13.'5' x '8' and had
an air exchange rate (AER) of 25/hr. Eighteen patient care workers familiar with ICU/OR units
were recruited from WVU Ruby Memorial Hospital. The choice of subject selection was based on
the previous or current experience of working in ICU/OR units. The eighteen patient care workers
were paired into nine teams. Each team was made to don six different RPDs while performing
typical OR activities such as CPR and reading a rainbow passage to simulate talking.

Fig 1. A standard simulated Operating Room at the WVU STEPS center.
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3.2.

Room Information

Two identical rooms were utilized for the main testing at STEPS. Parameters such as the room
size, the volume of air in cubic feet per minute (CFM), and air exchange rate (AER) were
considered important for the OR simulation. While different existing ORs utilize different AERs
depending on the age of the healthcare facility. Each room had a volume dimension of 13.'5' x
13.'5' x '8' and had an air exchange rate (AER) of 25/hr. Below is the information about the rooms
and air exchange rate available.

Rm. #

Area Cu. Ft.

3514

1456

125

5.15

680

28

3516

1456

125

5.15

880

38

3.3.

CFM Existing ACH

Max. Cfm Avail.

Avail. ACH

Materials

3.3.1 Respiratory Protection devices
Negative pressure respirators:

•

3M model 9205+ N95 flat-fold filtering facepiece respirator (FFR),

•

3M model 8511 N95 cup-shaped FFR with exhalation valve,

•

MSA Advantage 200 elastomeric respirator with exhalation valve, and

•

Disposable surgical mask (Sultan Healthcare)

PAPRs:

•

3M Versaflo™ Healthcare PAPR Kit TR-300N+ HKL,

•

Bullard EVA Powered Air Purifying Respirator (PAPR) System

Other materials

•

Remel 5% Blood Agar (TSA with Sheep Blood) Plate
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•

70% Isopropyl Alcohol from Decon Laboratories, Inc

•

Microflex Nitrile gloves

•

Ziploc bags

•

Porta Count Pro+ from TSI

•

Fisher Scientific Isotherm Incubator

3.3.2 Sampling Equipment
•

Andersen 6 Stage Viable Impactor Sampling System by Tisch Environmental

Flow Rate:

28.3 lpm

Particle Size:

0.85 to 10µm and above

•

Biostage Single-stage impactor by SKCinc (Required flow rate of 28.3l/min)

•

QuickTake 30 (with programmable timer) Sample Pump with rotameter, Li-Ion battery
pack, 110-240 V AC charger/adapter, cassette/tubing adapter, and tubing
Flow range: constant flow 10 to 30 L/min

Fig 2. Pictures of the biostage single-stage impactor with the quicktake 30 pump and the
andersen 6-stage viable impactor

3.3.3 Calibration and cleaning of devices
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Both sampling devices pump were calibrated to 28.3l/min pre and post-testing. Cleaning
and sterilization of apparel, the testing room, and equipment were done with a 70% solution
of isopropyl alcohol.

3.4.

Subjects Recruitment, Consenting and Medical Clearance

Eighteen healthcare workers from the WVU Ruby Memorial Hospital, Morgantown, WV were
recruited for the main OR study. The choice of subjects was based on previous or active
experience of working in healthcare or OR facilities. IRB approval with the consent number
(2009129419) from the WVU Ruby Memorial Hospital was obtained before conducting the
study. Subjects signed a consent form after a detailed explanation about the study was given and
also filled out an OSHA questionnaire to determine their eligibility to wear all the respirators
used for the study and were medically cleared (by Dr. Allen, co-investigator) before being
allowed to participate in the study.

3.5.

Fit Testing

The 18 subjects were fit tested for the two N-95 FFR and MSA Elastomeric half masks prior to
the main testing. Fit testing was conducted using a Porta Count Pro+. Each N-95 FFR was prepared
with an inlet so that the Porta Count could measure the concentration of particles in the respirator
while the MSA uses a fit testing adapter to connect it to the Porta Count.
A NaCl particle generator was used to produce aerosol for respirator fit testing. Once everything
was set up adequately, the instructions on the Porta Count were followed. Each fit test involved
the following tasks.
• Normal breathing
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• Deep breathing
• Head side to side
• Head up and down
• Talking
• Bending over
• Normal breathing
An overall fit factor of 100 or more had to be achieved to pass. All subjects needed to be trained
to don the respirator and had to pass the fit test before they could participate in the main testing.
The fit testing data can be referred to in the table section with the team composition.

3.6.

Experimental Procedures

The operating room activities involve teams of people (surgeon, charge nurse, anesthesiologist,
etc.). The minimum number of people on an OR team is two. To statistically handle data analysis
on teams of 2 that stayed together for testing all the respirators, a randomized block design
blocking on the subject and randomizing the RPDs was used. To reduce the chance of bacteria
becoming airborne from non-respiratory sources, each team member wore a full-body Tyvek suit
with hood and nitrile gloves over their street clothes and shoes. Pictures of each RPD while being
worn are provided in Figures 11-16. The order of testing of the six RPDs was randomized for each
team. In previous studies, a settled plate method was used to sample for CFU (Church, 2019),
(Grinshpun et al., 2016). These studies reported very low CFU counts. Most likely, the CFU counts
observed were the result of larger particles settling on the agar plates. Particle mechanics
calculations of settling times for unit density spheres indicates that the time to settle 5 ft ranges
from ≈41 hrs. for a 0.5µm particle to ≈8 minutes for a 10µm particle. As a result, active biological
sampling was chosen as the sampling method for this study.
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Active sampling of airborne bacteria was done using the Biostage Single-stage Impactor
by SKC Inc. Eighty-four, PA and the N-6 Andersen Viable Cascade Impactor (Tisch
Environmental Inc., Cleves, OH.). Both types of impactors were sampled at an airflow rate of
28.3 LPM. The pumps connected to the impactors were calibrated with a flowmeter pre and
post-sampling to a flow rate of 28.3LPM. Also, the minimum flowrate of each PAPR was
verified according to each ' 'manufacturer's instructions.
Figure 8 shows a schematic diagram of ' 'participant's placement during testing. Each team
member, wearing the same model of respirator, stood on each side of a manikin positioned on an
operating bed. One team member (L1) performs full chest compression CPR for 4 minutes on the
manikin while the other team member (L2) reads the """rainbow passage""" or engages in
conversation. After 4 minutes, both participants rest for 1 minute, then flip position on their side
of the bed so they can switch activities.
Five of the SKC Biostage Single-stage impactors and one N-6 Andersen Viable Cascade
Impactor were positioned on each side of the bed at three locations from the head of the bed, 1,
3, and 5 ft. The six-stage Andersen impactor (S1) was always located at the 1ft location. One of
the single-stage impactors (S2) was also located at the 1 ft location. Single-stage impactors, (S3)
and (S4) were positioned at 3ft from the head of the bed. Single-stage impactor, (S5) and (S6)
was also positioned at 5ft from the head of the bed as shown in Figure 9. All sampling devices
ran for 15 minutes at 28.3 LPM.
Background concentration levels of airborne bacteria serving as negative controls were measured
in each OR before each test sequence. The background data for the nine teams can be found in
the Appendix section. Due to COVID-19 guidelines involving the use of human participants in
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research, a positive control in which background concentration levels of airborne bacteria was
measured when subjects wore no respirators could not be conducted.
Given, we had nine teams, six RPDs, and three sample locations from the head of the bed
(samplers at the same position were averaged), a total of 162 airborne samples were collected.
The blood agar Petri plates were incubated at 37°C for 48 hours. After 48 hours, the number of
CFU was counted on each plate and converted to a concentration of CFU/m3 following the
procedure below.
Flow rate = a L/min. (28.3L/min)
Sampler running time = b minutes (15 minutes)
3

3

Volume of air sampled = a x b L = ab/1000 m = d m
Bacterial or mold count = c CFU
3

3

Total CFU/m air sampled = c/d CFU/m air
The independent variables are respirator types and sample locations(distance) on the operating
table. The dependent variable was the concentration of colony-forming units, CFU/m3. The six
RPDs tested (SM, 3M 9205+, 3M 8511, MSA, B-PAPR, V-PAPR) were tested in a randomized
order.
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Table 1. Respiratory Protection Devices evaluated
Negative Pressure RPD
SM
3M 9205+

3. 3M model 8511 N95 cup-shaped FFR with
exhalation valve

3M 8511

PAPRs

3.7.

1. Medical grade Cardinal Health Surgical mask
2. 3M model 9205+ N95 flat fold FFR without
exhalation valve

MSA

4. MSA Advantage 200 elastomeric respirator half
mask with exhalation valve

B-PAPR

5. Bullard EVA Powered Air Purifying Respirator
(PAPR) System

V-PAPR

6. 3M Versaflo™ Healthcare PAPR Kit TR-300N+
HKL

Data Analysis

Adapting a global significance level of 5% and power of at least 80%, the required sample size
was estimated to be two individuals per team (total of 9 teams) using six types of RPDs with
sample collection at 3 locations (162 in total). A randomized block design was used in which
each group participant wore one of six randomly assigned respirators to avoid habituation bias
and no order effect to develop a statistical model that did not violate the assumption of
independence between observations. The team composition was treated as part of the research
design and as a background variable, while the RPDs and distances are the independent
variables generating a response CFU counts (CFU/m3). Statistical analyses were performed
using IBM SPSS with Generalized Linear Model). Mean Colony-forming unit in CFU/m3 for
Respirator Types (SM, 3M 9205+, 3M 8511, MSA, B-PAPR, V-PAPR) and Distance (1ft,3ft and
5ft) were estimated.
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3.8.

Generalized Linear Model with Categorical Variables and it’s
assumptions

A Generalized Linear model analysis in IBM SPSS was performed on the dependent variable
Mean Colony-forming unit in CFU/m3 to test the effects of respirator types and sampling
distances (categorical variables) at the significance level of P < 0.05.
Model :
Y = α + β1 X + β 2 Y + Ɛ
Y – Effect of response, CFU/m3
α – Mean of CFU/m3
β1X – Effect of treatment, Respirator types
β2Y – Effect of treatment, Distance
Ɛ – Residual effect
The observations are assumed to be independent and the resulting distribution of the collective
individual CFU/m3 deviated from normality (Shapiro-Wilk <0.05) and took the form of a nonnegative, positively skewed, integer distribution.
Using a regression analytical framework to estimate the mean difference in CFUm3 between the
Respiratory protection devices, the fit of a Poisson distribution was examined in relation to the
Normal distribution. Consistent with the visual appearance of the data and the results of the
Shapiro-Wilk test, the Poisson distribution was found to provide a better fit through ' 'Akaike's
Information Criterion, Bayesian Information Criterion, and log-likelihood values.
Multivariate Poisson regression was used to examine differences in mean colony-forming unit
among the respirator types in relation to demographic characteristics, including the categorical
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variables distance (1ft, 3ft, 5ft), categorical Respirator Type (SM, 3M 9205+, 3M 8511, MSA,
B-PAPR, V-PAPR) were estimated.
The mean colony-forming unit concentration, CFU/m3 was calculated for each of the
respirators,surgical mask and aligned with each of the distances in the dataset using a categorical
variable. These categorical variables were entered into the regression models with the 1ft and the
SM as the reference input. This allowed for the comparison of the CFU/m3 at each of the other
categorical levels; distances (3 ft and 5 ft) and respirator types (3M 9205+, 3M 8511, MSA, BPAPR, V-PAPR) with the reference input of 1ft and SM respectively. A post hoc Bonferroni
pairwise comparison was also entered in the context of Poisson regression to do side by side
comparison to see if there is a significant difference between the CFU/m3 at the distance of 3ft
and 5 ft and between all the other Respirator Types, to determine their statistical significance.
Wald χ2 p-values <0.05 were considered statistically significant.
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Chapter 4: Results and Discussion
Eighteen participants were recruited into nine teams of two. The test of model effects (Omnibus
test) in Table 2 showed a significant effect with distance and respiratory protection devices. This
means that the concentration of CFU/m3 significantly varies as a function of distance and as a
function of respirator types. Total mean CFU/m3 at distances of 1ft, 3ft, and 5ft were 10.4, 8.9,
and 8.8, respectively. The total mean CFU/m3 for respirator type; SM, 3M 9205+, 3M 8511,
MSA, B-PAPR, V-PAPR were 7.9, 8.9, 11.7, 11.4, 7.8, and 8.9, respectively.
The percent difference, exp(B), at the distance of 3ft is 0.86 and 0.85 at the distance of 5ft. This
means that 86% and 85% of CFU/m3 are expected at the distance of 3ft and 5ft respectively when
compared to the distance of 1ft or a 14% and 15% average decrease at 3ft and 5ft respectively
compared to 1ft. Also, exp(B), for respirator type are as follows: 3M 9205+ (1.13), 3M
8511(1.48), MSA (1.44), B-PAPR (0.99), V-PAPR (1.13). This means that compared to the SM,
an average increase of 13% in the CFU/m3 concentration is expected when using the 3M 9205+,
an average increase of 48% in the CFU/m3 concentration when using the 3M 8511, an average
increase of 44% in the CFU/m3 concentration when using the MSA elastomeric respirator, an
average decrease of 1% in the CFU/m3 concentration when using the B-PAPR and an average
increase of 13% in the CFU/m3 concentration when using a V-PAPR. As reflected in Table 3, all
comparisons were significant for the effect of distance and for respirator types 3M 8511 FFR and
MSA elastomeric respirator, both of which have exhalation valves. No significant difference was
observed between the CFU/m3 concentration resulting from the use of the SM and the 3M 9205+
FFR without exhalation valve, the B-PAPR, and the V-PAPR respirators. Table 4 shows a post
hoc Bonferroni adjusted pairwise comparisons between the respirator types that was not
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answered with the regression table using a reference input. There is a significant difference in
CFU/m3 between the 3M 9205+ FFR without exhalation valve and the 3M 8511 FFR with
exhalation valve, but none of the other respirator types. The CFU/m3 produced while wearing
the 3M 8511 FFR with exhalation valve was not significantly different from the MSA
elastomeric respirator with exhalation valve, but it was significantly higher than with the 3M
9205+ FFR without exhalation valve, the B-PAPR, and the V-PAPR. The concentration of
airborne bacteria resulting from wearing the MSA elastomeric respirator with exhalation valve
was significantly higher than the concentration of airborne bacteria resulting from wearing the BPAPR; however, it was not significantly different from all the other respirator types. The
CFU/m3 concentration resulting from using the B-PAPR, was significantly lower than the
CFU/m3 concentration resulting from using the exhalation valved 3M 8511 FFR or the MSA
elastomeric respirators; however, there was no significant difference in the CFU/m3
concentration resulting from using the 3M 9205+ FFR without exhalation valve or the V-PAPR
respirators. The CFU/m3 concentration resulting from using the V-PAPR, was significantly lower
than the CFU/m3 concentration resulting from using the 3M 8511 FFR with exhalation valve;
however, the CFU/m3 concentration resulting from using the V-PAPR, was not significantly
different than the CFU/m3 concentration resulting from using all the other respirator types.
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Table 2. Tests of Model Effects
Type III
Source
Wald Chi-Square

df

P-Value

(Intercept)

7410.09

1

0.000

Distance

8.8

2

0.012

Respirator
Type

41.0

5

0.000

Dependent Variable: CFU/m3
Model: (Intercept), Distance, Respirator Type

Table 3. Mean CFU/m3 at different distances as compared to 1ft and for different respirator types
compared to the surgical mask
Parameters

Mean
CFU/m3

Std.
Error

95% Wald Confidence Interval Exp(B)
Lower

Upper

P-Value Exp(B)

Distance
1ft

10.4

1

3ft

8.9

0.06

0.76

0.97

0.02

0.86

5ft

8.8

0.06

0.75

0.96

0.01

0.85

RPDs
SM

7.9

1

3M 9205+

8.9

0.09

0.94

1.36

0.19

1.13

3M 8511

11.7

0.09

1.24

1.76

0

1.48

MSA

11.4

0.09

1.21

1.72

0

1.44

B-PAPR

7.8

0.1

0.82

1.19

0.88

0.99

V-PAPR

8.9

0.09

0.94

1.36

0.19

1.13

Table 4. Post hoc Bonferroni adjusted pairwise comparison of mean CFU/m3 concentration
between respirator types
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Pairwise Comparisons
Std.
Error

Bonferroni
Sig.

Lower

Upper

V-PAPR

0.0

0.81

1.00

-2.38

2.38

MSA

-2.5

0.87

0.06

-5.02

0.07

B-PAPR

1.1

0.79

1.00

-1.16

3.45

3M 8511

-2.7a

0.87

0.03

-5.29

-0.17

V-PAPR

2.7a

0.87

0.03

0.17

5.29

MSA

0.3

0.92

1.00

-2.45

2.97

B-PAPR

3.9a

0.85

0.00

1.39

6.37

3M 9205+

2.7a

0.87

0.03

0.17

5.29

V-PAPR

2.5

0.87

0.06

-0.07

5.02

B-PAPR

3.6a

0.84

0.00

1.15

6.09

3M 9205+

2.5

0.87

0.06

-0.07

5.02

3M 8511

-0.3

0.92

1.00

-2.97

2.45

V-PAPR

-1.1

0.79

1.00

-3.45

1.16

MSA

-3.6a

0.84

0.00

-6.09

-1.15

3M 9205+

-1.1

0.79

1.00

-3.45

1.16

3M 8511

-3.9a

0.85

0.00

-6.37

-1.39

MSA

-2.5

0.87

0.06

-5.02

0.07

B-PAPR

1.1

0.79

1.00

-1.16

3.45

3M 9205+

0.0

0.81

1.00

-2.38

2.38

3M 8511

-2.7a

0.87

0.03

-5.29

-0.17

Respirator Type

3M 9205+

3M 8511

MSA

B-PAPR

V-PAPR

95% Wald C. I

Mean
Difference
(I-J)

Pairwise comparisons of estimated marginal means based on the original scale
of dependent variable Rounded CFU
a

Means with the same superscript are not significantly different at the .05 level.

4.1. Particle size Analysis
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The bioaerosol samples collected with the six-stage Viable Cascade Impactor were used to
determine the aerodynamic diameter of the bioaerosol exhaled from each respirator type. With
the nine teams, we had 9, six-stage Viable Cascade Impactor samples collected on each
respirator type. These agar plates were handled and incubated as the single-stage agar plates. The
geometric mean (GM) and geometric standard deviation (GSD) calculated for each respirator
type are given in Table 5, and the cumulative distribution from the exhaled breath resulting from
wearing each respirator type are plotted in Figure 2.
Table 5. Aerodynamic Diameter GM and GSD for exhaled breath aerosol while wearing
different respirator Types.
Geometric mean (GM)
aerodynamic diameter

Geometric Standard
Deviation (GSD)

Surgical Mask

6.0

2.83

3M 9205+

8.0

3.50

3M 8511

6.4

2.96

MSA elastomeric half-mask

7.2

3.30

B-PAPR

9.8

3.67

V-PAPR

4.3

2.79

Respirator Type

Discussion
This study measured the CFU/m3 concentration of airborne colony forming bacteria resulting
from the use of different types of respirators, as compared to a typical surgical mask, when used
in a simulated operating room environment with users doing CPR and talking activities. The
results of the experiments revealed that on the average, the airborne bacterial shedding in the
sterile field of an operating room by a pair of subjects wearing PAPRs, with different assigned
protection factors of 25 and 1000, does not significantly increase the bacterial concentration of
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the sterile field when compared to the use of a surgical mask, which is the standard face-covering
commonly employed in surgical room settings. The data revealed that the mean CFU/m3
concentration resulting from using a SM is not statistically significantly different from the mean
CFU/m3 concentration resulting from using an N95 FFR without exhalation valve, the loosefitting facepiece B-PAPR (APF = 25), or the full facepiece V-PAPR (APF= 1000). However, the
N95 FFR with exhalation valve and the elastomeric half mask with exhalation valve generated
statistically significantly higher CFU/m3 concentrations than the SM, N95 FFR without
exhalation valve, B-PAPR (APF of 25), or the V-PAPR (APF of 1000).
The volume of air exhaled by wearers of a PAPRs is simply diluted by the airflow minute
volume of the PAPR, which must be a minimum of 170LPM for certification by NIOSH. The
diluted exhaled volume is then released into the surrounding environment. Based on this
operational feature, it would be expected that the PAPRs would generate more exhalationassociated bacterial contamination than wearers of the N95 FFR. However, the results of this
study found that the airborne concentration of CFU/m3 resulting from using either of the tested
PAPR models did not significantly differ from the airborne concentration of CFU/m3 resulting
from using the N95 FFR respirator without an exhalation valve or the typically used SM. This
result might be explained if the CPR and talking activities used in the simulated OR caused
increased face seal leakage with the tight-fitting N95 FFR without exhalation valve or the loosefitting SM, particularly during the exhalation cycle.
The data also revealed that the N95 FFR with exhalation valve generates significantly more
bacterial contamination of the sterile field than the N95 FFR without an exhalation valve. No
significant difference was found between the PAPR with an APF of 25 versus the PAPR with an
APF of 1000.
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A positive control, measuring the concentration of CFU/m3 from test participants without
wearing any respirator, could not be done due to COVID guidelines from the of WVU IRB
restricting the use of research participants without wearing face covering. We believe an
inclusion in future study would be beneficial because it helps refine the study methodology and
allows for an independent database on the OR sterile field bio-contamination by unprotected
healthcare workers. Other RPDs models can also be tested to see if there is any correlation with
the RPDs used in this study.
The cumulative distribution plots indicated that 10% of the size of the exhaled breath bioaerosol
was below approximately 1.6 µm with the SM, the 3M9205+, the 3M 8511, and the MSA
Advantage 200 elastomeric respirators, while with the B-PAPR it was approximately 1.9 µm and
for the V-PAPR it was 1.2 µm. The particle size data suggest that while wearing one of the
respirator types used in this study, very little exhaled breath bioaerosol from these devices is
smaller than about 1.5 µm (Figure 10). This could be a lower limit to the exhaled breath particle
size. It should also be pointed out that it could also indicate that even with using active sampling
and two test participants over a 15-minute test time, that particles below 1.5 µm were not in
sufficient number or 'didn't have time to settle sufficiently to be sampled with the active
samplers.
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Fig 3. Exhaled Particle Distribution Produced While Doing CPR and Talking While Wearing
Different Types of Respirators.
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Chapter 5: Conclusion
The bacterial contamination of the sterile field by a pair of subjects wearing N95 FFR without
exhalation valves, loose-fitting facepiece PAPRs or a full facepiece PAPRs was not significantly
different from wearers of the SM. The N95 FFR with exhalation valve and EHMR with
exhalation valve were found to generate significantly higher bacterial contamination of the sterile
field than the SM, the N95 FFR without exhalation valve, or the two PAPRs. The airborne
bacterial concentration resulting from using the N95 FFR with exhalation valve or the EHMR
with exhalation valve were not significantly different. No significant difference was found in
contamination between the PAPR with a loose-fitting oralnasal covering (APF=25) and the
PAPR with hood and shroud (APF=1000).
This study found that using a SM, N95FFR without EV, and PAPRs equipped with loosefitting oralnasal covering or hood and shroud resulted in equivalent levels of bacterial
contamination of a sterile field. The benefits of a PAPR during an emergency or crisis can be
invaluable, especially one that requires no fit testing to be completed. This research suggests
that a PAPR could be used in a sterile field area such as an OR and not lead to bacterial
contamination greater than what would occur with a SM . This is an important finding especially
during a pandemic when PPE such as N95 FFRs may be in short supply., Another viable option,
requiring more testing would be to evaluate new designs of EHMRs not equipped with an EV.
The findings of the research may be used for future research purposes and have the potential to
foster more controlled experimental research that is vital to understanding and improving the use
of different types of respirators used by HCWs in healthcare settings.

Limitations, Overall Conclusions, and Future Directions
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Limitations
There are still some limitations in this study.
1. Due to COVID-19 guidelines involving the use of human participants in research, a
positive control, in which background concentration levels of airborne bacteria was
measured when subjects wore no respirators, could not be taken.
2. Aerodynamic particle size evaluation of the bacteria shed from the test participants
indicate that only a small percentage of particles were as small as virus size particles.
Sampling for actual virus particles was not done because of the extensive means required
to grow them so they could be counted. Therefore applying conclusions and findings
made with airborne size bacteria to actual virus particles needs to carefully considered.
Due to the limited number and variety of tasks assessed in this study, it is important to not
over-interpret the study findings to the broader list of HCW activities in sterile field areas
such as ORs and ICUs.

Overall Conclusions
In summary, the data reported in this dissertation addresses the issue of bio-contamination of
the sterile field in the operating room resulting from HCWs, using different types of RPD as
compared to the common, medical grade SM. The information from the study could also
served as guidance for respirator manufacturers, regulatory agencies, and respiratory
protection researchers when designing, certifying, and testing respirators to be used in the
healthcare environment. RPD have often been studied as an exposure control for workers in
many industrial applications. In this use application however, the RPD must be evaluated as a
source control limiting bacterial-contamination from the exhaled air of the RPD wearer to a
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sterile field environment, such as an OR, or a patient. It is a unique role for the RPD to be
evaluated as both a source control and as an exposure control. In these types of roles, the
RPD selection criteria must consider the RPD’s ability to protect the HWC using it for their
personal protection as well as to protect the patient from the exhaled air of the HWC wearing
the respirator.

Future Directions
The following five main directions are to be considered for the future research efforts:
1. If allowable by IRB human participant review board, testing should include a positive
control to determine bacterial shedding rates when subjects are not wearing a RPD.
2. Additional testing should be done to include new designs of EHMR not equipped with an
exhalation valve, or EHMRs equipped with device to filter exhaled breath.
3. A teams of more than 2 subjects should be used to see if there is increase in
contamination with more people in the OR sterile field.
4. Additional evaluation to determine if different task activities covering light, medium and
heavy minute volumes affects bacterial shredding rates.
5. Additional evaluation of appropriate sampling times should be done to confirm the
suitability of the 15 minute sample time used in this study.
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FIGURES
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Fig. 4 – Medical Grade Surgical Mask
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Fig. 5 – 3M N95 8511 cup-shaped respirator (external and internal)
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Fig. 6 – 3M N95 9205+ flat-fold respirator (External and internal)
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Fig. 7 – MSA Advantage 200LS elastomeric half-mask respirator (External and Internal)
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Fig. 8 – Bullard EVA Powered Air-Purifying Respirator with Loose Fitting Hood
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Fig. 9 – 3M Versaflo TR-300 TR-300N +ECK PAPR Assembly kit with headpiece
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Fig. 10 - Sampling Devices and subject placement around the patient simulated manikin
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Fig. 11 – Participants wearing surgical mask(SM) and performing simulated activities

Fig. 12 – Participants wearing 3M N95 9205+ and performing simulated activities
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Fig. 13 – Participants wearing 3M N95 8511 and performing simulated activities

Fig. 14 – Participants wearing MSA half mask (EHMR) and performing simulated
activities
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Fig. 15 – Participants wearing Bullard EVA PAPR and performing simulated activities

Fig.16 - Participants wearing 3M Versaflo PAPR and performing simulated activities
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TABLES
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Table 6. Participants Gender, Age, Height, Average Age, Average Weight and Average
Height

Team
1
1
2
2
3
3
4
4
5
5
6
6
7
7
8
8
9
9

Gender
M
M
F
F
M
M
M
F
F
F
F
F
F
F
M
F
M
M

Age Weight (Ibs)
Height(cm)
Avg Age
35
340
170
24
142
178
29.5
30
130
163
24
140
168
27
35
185
191
41
250
191
38
48
225
183
40
200
165
44
29
148
160
29
104
155
29
23
125
163
23
125
155
23
26
160
165
42
148
163
34
29
200
180
23
160
185
26
49
280
191
22
280
198
35.5
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Avg. Weight

Average height

241

174

135

165.5

217.5

191

212.5

174

126

157.5

125

159

154

164

180

182.5

280

194.5

Table 7. Participants fit testing overall fit factor results
Overall Fit Factor
Team No
T1
T1
T2
T2
T3
T3
T4
T4
T5
T5
T6
T6
T7
T7
T8
T8
T9
T9

3M N95 8511(100)
194
200+
200+
200+
200+
200+
200+
200+
128
163
192
181
200+
200+
195
200+
200+
200+

3M N95 9205+(100)
200+
200+
200+
200+
200+
200+
200+
200+
200+
142
169
200
200+
200+
136
143
141
200+
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MSA
(100)
Passed(M)
Passed(M)
Passed(M)
Passed(S)
Passed(M)
Passed(M)
Passed(M)
Passed(S)
Passed(S)
Passed(M)
Passed(S)
Passed(M)
Passed(M)
Passed(M)
Passed(M)
Passed(M)
Passed(M)
Passed(M)

Table 8. Background Airborne CFU/m3 for each of the Nine Teams of study participants

Team
1
2
3
4
5
6
7
8
9

Background
CFU/m3 levels
1.8
1.2
0.6
3.3
6.2
3.3
1.8
6.5
3.0
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